Dr.GIRISH BOLAKATTI
M.Pharm
Principal
Field of Specialization | Pharmaceutical Chemistry |
Office Contact Details with Ph. No | Department of Pharmaceutical Chemistry GM Institute of Pharmaceutical Sciences and Research, Davanagere 577006, Karnataka, India 08192 223599/233377 |
Mobile number | 9901499119 |
E- mail | principal@gmipsr.ac.in |
Residential Address | #1822/76, Samarth Nilay, 6th Cross, A Block, SS Layout, Davangere-577004 |
Date of joining | 03/09/2018 |
Blood Group | AB+ve |
Area of Research |
SI.NO | Name of the conference and Topic |
01 |
Conference: A Three Days National Symposium On Innovative Skills of Young Talents in Pharmacy Topic: Synthesis and antitumor activity of 2-(4-aminophenyl)-6-fluoro-N-(substituted-phenyl)benzo[d]thiazol-7-amine derivatives: A novel class of anticancer agents Date: 24-26th Nov 2013 |
02 |
Conference: One day International Conference on Nanopharmaceutical Therapeutics: From Laboratory to Clinical Practice. Topic: Synthesis and antimicrobial activity of 3-(2-(6,7-substitutedbenzo[d]thiazol-2-ylamino)acetyl)-2H-chromen-2-one Date:24th Sept 2012 |
03 |
Conference: Two days ICMR sponsored National Conference on “Role of organic chemical intermediates in cognitive disorders and mental health” Topic: Design, Synthesis and screening of 2-(4-(benzo[d]thiazol-2-yl)phenylamino)-N-(substituted-phenyl)acetamide: as a phortress anticancer analogues Date:24th Sept 2012 |
SI.NO |
Authors, Title of the paper, Journal name, vol no, page no |
01 |
Girish Bolakatti*, Arvind Badiger, ManjunathaKatagi, Narayan Miskin, Muralikrishna K.S. Synthesis and antitumor activity of 2-(4-aminophenyl)-6-fluoro-N-(substitutedphenyl)benzo[d]thiazol-7-amine derivatives: A novel class of anticancer agents. RGUHS Journal of Pharmaceutical Sciences (RJPS): 2014; 04(1): 22-29 |
02 |
Girish S. Bolakatti,Veeresh S. Maddi, Shivalingarao N. Mamledesai, Pradeep M. Ronad, Mahesh B. Palkar,Shivakumar Swamy. Synthesis and Evaluation of Antiinflammatory and Analgesic Activities of a Novel Series of Coumarin Mannich Bases. Arzneimittel-Forschung(Drug Research) (Impact factor: 0. 762) 2008; 58(10):515–520. Citation: 20 |
03 |
M.S.Katagi, G.S.Bolakatti*, A.M.Badiger, D.Satyanarayana, S.N.Mamledesai, M.L.Sujatha“Synthesis, Spectral Characterization and Antimicrobial Activity of Substituted Thiazolyl Derivatives of 2-Quinolones” Arznemittel-Forchung (Drug Research): 2013; 63(1): 53-59. (Impact factor: 0. 762) DOI http://dx.dpi.org/10.1055/s-0032-1331711. Citation: 03 |
04 |
Girish Bolakatti*, Arvind Badiger, ManjunathaKatagi, Narayan Miskin, Prakash Dabadi, Muralikrishna K.S. Synthesis and Pharmacological evaluation of novel series of Benzthiazolyl-Coumarin conjugates: As Anti-inflammatory and Anticancer agents. Universal Journal of Pharmacy. 2013: 02(03); 148-154. |
05 |
D.K.Ramesh, B.Gopalkrishna, J.H.Mruthyunjaya, Manjunath.S.Katagi, Girish Bolakatti. “Synthesis Antimicrobial Evaluation of Newly Synthesized TriazolothiadiazoleAnalogs” International Journal of Drug Design and Discovery. 2013; 4(2): 1050-1055. |
06 |
Girish Bolakatti, Manjunatha S. Katagi*, S.N. Mamledesai, Sujatha. M.L, Prakash Dabadi, Narayana Miskin. “Synthesis and antimicrobial activity of 4-hydroxy-1-methyl/phenyl-3- (substituted anilinoacetyl) quinolin-2(1 H)-one” RGUHS Journal of Pharmaceutical Sciences.2012; 2(1): 60-65. DOI http://dx.dpi.org/10.5530/rjps.2012.2.B. |
07 |
Narayan Miskin, K.P.Manjunath, Anant Bhandarkar, Girish Bolakatti, Manjunath Katagi. “Antipyretic activity of Vitex negundo Linn Leaves extracts” RGUHS Journal of Pharmaceutical Sciences 2012; 2(2): 78-81.DOI http://dx.dpi.org/10.5530/rjps.2012.1.11. |
08 |
VirupaxappaB.S,RavirajM.Kulkarni, Girish Bolakatti, Shivaprasad K.H, Latha.M.S. “Kinetic spectrophotometric determination of fluoroquinolines in pharmaceutical formulations” Recent Advances in Pharmaceutical Science Research. 2012; 1(1): 60-70. |
09 |
Mahesh B. Palkar*, Sunil S. Jalalpure, Rajesh A. Rane, Harun M. Patel, Mahamadhanif S. Shaikh, Girish A. Hampannavar, Wesam S. Alwan, Girish S. Bolakattiand RajshekharKarpoormath. Novel Series of Coumarinyl Substituted-thiazolidin-2,4-dione Analogs as Anticancer Agents: Design, Synthesis, Spectral Studies and Cytotoxicity Evaluation. Anti-Cancer Agents in Medicinal Chemistry (Impact factor: 2.96): 2015;15(8):970-9. |
10 |
Katagi, Manjunatha S., Fernandes Jennifer, D Satyanarayana, Bolakatti Girish, and S.N.Mamledesai.In vitro Reactivation of Chlorpyrifos-inhibited Rat Brain Acetylcholinesterase from 2-Quinolone Substituted Thiazole derivativesRGUHS Journal of Pharmaceutical Sciences.2014; 4(2): 57-61. DOI: 10.5530/rjps.2014.2.4 |
11 |
Manjunatha S. Katagi, Jennifer Fernandes, ShivlingraoMamledesai, D. Satyanarayana, Prakash Dabadi, Girish Bolakatti. Synthesis and evaluation of quinolin-2(1H)-one fused oxazole as an in vitro reactivator of organophosphorus compound inhibited acytylcholinestrerase. Journal of Pharmaceutical Research 2015; 14 (2): 51-56 |
12 |
Manjunatha S. Katagi, Jennifer Fernandes, ShivalingraoMamledesai, Sujatha M.L., Rekha A., Girish Bolakatti*. Schiff Base Oxime Derivatives Reactivate Chlorpyrifos-induced Acetylcholinesterase Inhibition. INNOSC Theranostics and Pharmacological Sciences, 2019 Vol 2 No 1, 14-18. |
13 |
Arvind Badiger ,Girish Bolakatti* , ManjunathaKatagi , P Vasudeva Nayak. Design, synthesis and cytotoxic activity of clinical candidate Phortress analogues of benzothiazolylpyrimidine and benzothiazolyldihydropyrimidine derivatives. J. Pharm. Sci. & Res. Vol. 12(5), 2020, 673-679. |
14 |
Manjunatha S Katagi, ShivlingraoMamledesai, Girish Bolakatti, Jennifer Fernandes, ML Sujatha, Prassad Tari. Design, synthesis, and characterization of novel class of 2-quinolon-3-oxime reactivators for acetylcholinesterase inhibited by organophosphorus compounds. Chemical Data Collections, 30, 2020, 100560 |
15 |
Girish Bolakatti*,Mahesh PalkarManjunathaKatagiGirish HampannavarRajshekharV.KarpoormathShilpa Ninganagouda, Arvind Badiger. Novel series of benzo[d]thiazolyl substituted-2-quinolone hybrids: Design, synthesis, biological evaluation and in-silico insights. Journal of Molecular Structure,Volume 1227, 5 March 2021, 129413.(Impact factor: 3.196). |
16 |
Narayan R Miskin, Manjunatha S Katagi, Girish Bolakatti, Vishvakarma kamala Sunita, Suchitra M In-Vitro Cytotoxic Activity of Persea Americana Miller Leaves Extracts. Int. J. Med. Pharm. Res., 2020, 8(2): 21-25. |
17 |
Pradeep H K, Thimmasetty J, Sandeep DS, Girish B. Rapimelts of Venlafaxine Hydrochloride – An Approach to Formulation and In – VitroEvaluation.RJPS.2016;6(2):23-32 |
18 |
HeregangurKeshavamurthySetty Pradeep, Nooruddin K, JuturuThimmasetty, Bolakatti Girish, VenkateswarluBendi Sri.Design and In-Vivo Evaluation of Risperidone BuccalMucoadhesive Patches of Interpolymer Matrix. Res. Jour of Pharm Tech.2021:14(10). |
19 |
Madhuri HR, Pradeep H K, Shankarayya M, Prateeksha CC, Girish B. Formulation and evaluation of tailored interpenetrating polymeric network (IPN) beads of trimetazidine dihydrochloride for controlled drug delivery. Jour.of Xian shiyou Uni.2021:17(10);392-98. |
20 |
Jennifer Fernandes, Manjunath S. Katagi, Girish Bolakatti, BP Nandeshwarappa, Sujatha ML, DK Ramesh and ShivlingraoMamledesai. Pyrazole-oxime as reactivator for Chlorpyrifos inhibited AChE: Synthesis and In Vitro reactivation study. This above work communicated to Thai Journal of Pharmaceutical Sciences (TJPS) (Accepted & In Press). |
SI.NO |
Title of Project |
Funding Agency |
Amount in lakhs |
01 |
Principal Investigator for Research project entitled “Design and Development of Phortress analogue: as anticancer agent” (Order no: RGU:Adv.Res: Proposal-P-141: 2014-15 Dated: 06/01/2016) |
Rajiv Gandhi University of Health Sciences, Bangalore |
Rs 3.50.000/- |
02 |
Co-Principal Investigator for Research project entitled “Development of Oxime derivatives as a potential antidote for Organophosphorous Poisoning” (Order no: RGU:Adv.Res: Proposal-P-139: 2014-15 Dated: 06/01/2016) |
Rajiv Gandhi University of Health Sciences, Bangalore |
Rs 2.50.000/- |
03 |
Co-Principal Investigator for Research project entitled “Development of natural Products from traditional drugs as novel anticancer agents” (Order no: RGU:Adv.Res: Proposal-P-143: 2014-15 Dated: 06/01/2016) |
Rajiv Gandhi University of Health Sciences, Bangalore |
Rs 1.50.000/- |